Immediate Impact
1 by Nobel laureates 2 from Science/Nature 61 standout
Citing Papers
Discovery of antimicrobial peptides with notable antibacterial potency by an LLM-based foundation model
2025 Standout
Expanded ROS Generation and Hypoxia Reversal: Excipient‐free Self‐assembled Nanotheranostics for Enhanced Cancer Photodynamic Immunotherapy
2024 Standout
Works of Sarah Sarker being referenced
A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Sarah Sarker | 91 | 9 | 14 | 18 | 17 | 2 | 104 | |
| Jessica Perrin | 122 | 10 | 23 | 12 | 28 | 5 | 176 | |
| Evangelia Vartholomaiou | 110 | 2 | 8 | 14 | 9 | 5 | 117 | |
| Mairi Challinor | 122 | 7 | 20 | 25 | 34 | 6 | 163 | |
| Bram Stynen | 153 | 8 | 8 | 32 | 8 | 3 | 193 | |
| Kamal R. Abdul Azeez | 105 | 4 | 35 | 43 | 14 | 5 | 176 | |
| Frances M. Pool | 91 | 6 | 6 | 8 | 7 | 3 | 187 | |
| M. Szklarz | 100 | 3 | 25 | 26 | 15 | 3 | 176 | |
| Guanjing Chen | 121 | 3 | 33 | 17 | 45 | 4 | 178 | |
| C. Hamlett | 119 | 3 | 15 | 6 | 28 | 5 | 184 | |
| Vladimir Rynkov | 196 | 13 | 14 | 12 | 34 | 3 | 249 |
All Works
Login with ORCID to disown or claim papers
Loading papers...